ViiV Healthcare Announces FDA Approval of Once-Daily Treatment for Children Living with HIV

ViiV Healthcare announced that FDA has approved Triumeq PD, a dispersible single tablet regimen containing dolutegravir, a once-daily treatment for children living with HIV.